M&A Deal Summary

IQVIA Acquires Advion BioServices

On November 7, 2011, IQVIA acquired life science company Advion BioServices

Acquisition Highlights
  • This is IQVIA’s 5th transaction in the Life Science sector.
  • This is IQVIA’s 8th transaction in the United States.
  • This is IQVIA’s 2nd transaction in New York.

M&A Deal Summary
Date 2011-11-07
Target Advion BioServices
Sector Life Science
Buyer(s) IQVIA
Deal Type Add-on Acquisition

Target

Advion BioServices

Ithaca, New York, United States
Advion BioServices, Inc. is a premier U.S.-based bioanalytical laboratory. Company provides Good Laboratory Practice (GLP) pharmacokinetic/pharmacodynamic (PK/PD) testing and other services to biopharma companies worldwide.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

IQVIA

Durham, North Carolina, United States
Category Company
Sector Life Science
Employees87,000
Revenue 15.0B USD (2023)
DESCRIPTION
Quintiles office in San Diego, California.
Quintiles office in San Diego, California.

IQVIA is a provider of advanced analytics, technology solutions, and contract research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. IQVIA was founded in 2016 and is based in Durham, North Carolina.

DEAL STATS #
Overall 9 of 18
Sector (Life Science) 5 of 8
Type (Add-on Acquisition) 8 of 15
State (New York) 2 of 2
Country (United States) 8 of 15
Year (2011) 5 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-10-27 Advion

Ithaca, New York, United States

Advion is a leading provider of bioanalytical services to the pharmaceutical industry, and a developer of automated, chip-based technology designed to boost the sensitivity, data quality and sample throughput for electrospray mass spectrometers

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-08-13 Expression Analysis

Durham, North Carolina, United States

Expression Analysis, Inc. is a provider of genomics testing and analysis to biopharma, academic, government and non-profit customers. EA provides whole genome to focused-set gene expression and genotyping assays, along with next-generation sequencing services, sequence enrichment technologies and bioinformatics support.

Buy -
Mergr

Product

Company

Legal